Furthermore, using human tumour cell lines, the investigation also reveals that suppression of FOXC2 by short hairpin RNA (shRNA) in an aggressive metastatic breast cancer model could halt the metastatic tendency (92) suggesting that FOCX2 is not only a promising molecular marker for cancer detection but also a potential therapeutic target. Here, FOXC2 is linked to cancer.